Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 8, 2012, Pages

  Coronado, Michael J ^a   Brandt, Jessica E ^a   Kim, Eunyong ^a   Bucek, Adriana ^a   Bedja, Djahida ^b   Abston, Eric D ^a   Shin, Jaewook ^a   Gabrielson, Kathleen L ^b   Mitzner, Wayne ^a   Fairweather, Delisa ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Dilated cardiomyopathy; Myocarditis; Sex differences

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; GELATINASE B; INTERLEUKIN 1BETA; MESSENGER RNA; NEUTROPHIL COLLAGENASE; STROMELYSIN; TESTOSTERONE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DISEASE COURSE; DISEASE SEVERITY; ENZYME REPRESSION; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GONADECTOMY; HEART DISEASE; HEART MUSCLE FIBROSIS; HEART REMODELING; HUMAN; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; SEX DIFFERENCE; TISSUE LEVEL; UPREGULATION; VIRUS MYOCARDITIS; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ACUTE-PHASE PROTEINS; ANIMALS; AUTOIMMUNE DISEASES; COXSACKIEVIRUS INFECTIONS; CYTOKINES; DISEASE PROGRESSION; FEMALE; FIBROSIS; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED BALB C; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; MYOCARDITIS; MYOCARDIUM; ORCHIECTOMY; OVARIECTOMY; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SERPINS; SEX CHARACTERISTICS; TESTOSTERONE; VENTRICULAR REMODELING; VIRAL PLAQUE ASSAY;

EID: 84859771703     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00783.2011     Document Type: Article

References (46)

1. Asakura M, Kitakaze M. Global gene expression profiling in the failing myocardium. Circ J 73: 1568-1576, 2009.
2. Barth AS, Kuner R, Buness A, Ruschhaupt M, Merk S, Zwermann L, Kääb S, Kreuzer E, Steinbeck G, Mansmann U, Poustka A, Nabauer M, Sültmann H. Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. J Am Coll Cardiol 48: 1610-1617, 2006.
3. Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis 52: 274-288, 2010.
4. Brauer PR. MMPs-role in cardiovascular development and disease. Front Biosci 11: 447-478, 2006.
5. Caforio ALP, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28: 1326-1333, 2007.
6. Cavasin MA, Tao ZY, Yu AL, Yang XP. Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function. Am J Physiol Heart Circ Physiol 290: H2043-H2050, 2006.
7. Chen MC, Schuit F, Pipeleers DG, Eizirik DL. IL-1β induces serine protease inhibitor 3 (Spi-3) gene expression in rat pancreatic β -cells. Detection by differential display of messenger RNA. Cytokine 11: 856-862, 1999.
8. Cheung C, Marchant D, Walker EKY, Luo Z, Zhang J, Yanagawa B, Rahmani M, Cox J, Overall C, Senior RM, Luo H, McManus BM. Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice. Circulation 117: 1574-1582, 2008.
9. Cihakova D, Barin JG, Afanasyeva M, Kimura M, Fairweather D, Berg M, Talor MV, Baldeviano GC, Frisancho-Kiss S, Gabrielson K, Bedja D, Rose NR. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am J Pathol 172: 1195-1208, 2008.
10. Cocker MS, Abdel-Aty H, Strohm O, Friedrich MG. Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study. Heart 95: 1925-1930, 2009.
11. Cooper LT Jr. Myocarditis. N Engl J Med 360: 1526-1538, 2009.
12. Cooper LT Jr, Onuma OK, Sagar S, Oberg AL, Mahoney DW, Asmann YW, Liu P. Genomic and proteomic analysis of myocarditis and dilated cardiomyopathy. Heart Fail Clin 6: 75-85, 2010.
13. Crocker SJ, Frausto RF, Whitmire JK, Benning N, Milner R, Whitton JL. Amelioration of coxsackievirus B3-mediated myocarditis by inhibition of tissue inhibitors of matrix metalloproteinase-1. Am J Pathol 171: 1762-1773, 2007.
14. Fairweather D, Rose NR. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41: 118-122, 2007.
15. Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, Steele R, Rose NR. IL-12R β 1 and TLR4 increase IL-1 β and IL-18-associated myocarditis and coxsackievirus replication. J Immunol 170: 4731-4737, 2003.
16. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Gatewood SJL, Davis SE, Njoku DB, Rose NR. IFN- γ protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines TGF- β 1, IL-1 β, and IL-4 in the heart. Am J Pathol 165: 1883-1894, 2004.
17. Fairweather D, Frisancho-Kiss S, Rose NR. Viruses as adjuvants for autoimmunity: evidence from coxsackievirus-induced myocarditis. Rev Med Virol 15: 17-27, 2005.
18. Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, Cihakova D, Rose NR, Fairweather D. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol 178: 6710-6714, 2007.
19. Frisancho-Kiss S, Coronado MJ, Frisancho JA, Lau VM, Rose NR, Klein SL, Fairweather D. Gonadectomy of male BALB/c mice increases Tim-3 alternatively activated M2 macrophages, Tim-3 T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav Immun 23: 649-657, 2009.
20. Fuse K, Chan G, Liu Y, Gudgeon P, Husain M, Chen M, Yeh WC, Akira S, Liu PP. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 112: 2276-2285, 2005.
21. Gjesdal O, Bluemke DA, Lima JA. Cardiac remodeling at the population level- risk factors, screening, and outcomes. Nat Rev Cardiol 8: 673-685, 2011.
22. Haddad GE, Saunders LJ, Crosby SD, Carles M, del Monte F, King K, Bristow MR, Spinale FG, Macgillivray TE, Semigran MJ, Dec GW, Williams SA, Hajjar RJ, Gwathmey JK. Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences. Physiol Genomics 33: 267-277, 2008.
23. Heidecker B, Kittleson MM, Kasper EK, Wittstein IS, Champion HC, Rissell SD, Hruban RH, Rodriguez ER, Baughman KL, Hare JM. Transcriptomic biomarkers for the accurate diagnosis of myocarditis. Circulation 123: 1174-1184, 2011.
24. Heymans S, Sschroen B, Vermeersch P, Milting H, Gao F, Kassner A, Gillijns H, Herijgers P, Flameng W, Carmeliet P, van de Werf F, Pinto YM, Janssens S. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibiter of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 23: 1136-1144, 2005.
25. Hoffmann DC, Textoris C, Oehme F, Klaassen T, Goppelt A, Romer A, Fugmann B, Davidson JM, Werner S, Krieg T, Eming SA. Pivotal role for α1-antichymotrypsin in skin repair. J Biol Chem 286: 28889-28901, 2011.
26. Horvath AJ, Forsyth SL, Coughlin PB. Expression patterns of murine antichymotrypisn-like genes reflect evolutionary divergence at the Serpina3 locus. J Mol Evol 59: 488-497, 2004.
27. Horvath AJ, Irving JA, Rossjohn J, Law RH, Bottomly SP, Quinsey NS, Pike RN, Coughlin PB, Whisstock JC. The murine orthologue of human antichymotrypsin: a structural paradigm for clade A3 serpins. J Biol Chem 280: 43168-43178, 2005.
28. Kania G, Blyszczuk P, Eriksson U. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med 19: 247-252, 2009.
29. Klein SL, Bird BH, Glass GE. Sex differences in Seoul virus infection are not related to adult sex steroid concentrations in Norway rats. J Virol 74: 8213-8217, 2000.
30. Krieg M, Smith K, Bartsch W. Demonstration of a specific androgen receptor in rat heart muscle: relationship between binding, metabolism, and tissue levels of androgens. Endocrinology 103: 1686-1694, 1978.
31. Lubos E, Schnabel R, Rupprecht HJ, Bickel C, Messow CM, Prigge S, Cambien F, Tiret L, Munzel T, Blankenberg S. Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study. Eur Heart J 27: 150-156, 2005.
32. Lui P, Sun M, Sader S. Matrix metalloproteinases in cardiovascular disease. Can J Cardiol 22, Suppl B: 25B-30B, 2006.
33. McNamara DM, Starling RC, Cooper LT, Boehmer JP, Mather PJ, Janosko KM, Gorcsan J 3rd, Kip KE, Dec GW; IMAC Investigators. Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study. J Am Coll Cardiol 58: 1112-1118, 2011.
34. Melchert RB, Kennedy RH, Acosta D Jr. Cardiovascular effects of steroidal agents. In: Cardiovascular Toxicology, edited by Acosta D Jr. London: Taylor & Francis, 2001, p. 425-475.
35. Morihara T, Teter B, Yang F, Lim GP, Boudinot S, Boudinot FD, Frautschy SA, Cole GM. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic α 1-antichymotrypsin to ameliorate β -amyloid (A β) pathology in Alzheimer's models. Neuropsychopharmacology 30: 1111-1120, 2005.
36. Nikolic I, Liu D, Bell JA, Collins J, Steenbergen C, Murphy E. Treatment with an estrogen receptor- β -selective agonist is cardioprotective. J Mol Cell Cardiol 42: 769-780, 2007.
37. Onyimba JA, Coronado MJ, Garton AE, Kim JB, Bucek A, Bedja D, Gabrielson KL, Guilarte TR, Fairweather D. The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice. Biol Sex Differ 2: 2, 2011.
38. Regitz-Zagrosek V, Oertelt-Prigione O, Seeland U, Hetser R. Sex and gender differences in myocardial hypertrophy and heart failure. Circ J 74: 1265-1273, 2010.
39. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J, American Heart Association Statistics Committee, and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update. Circulation 123: e18-e209, 2011.
40. Shen D, Tang Q, Huang Z, Chen Y, Xiong R, Wu H, Huang J, Feng S, Yan L, Bian Z. The effects of NK4 on viral myocarditis in mice. Cardiovasc Pathol 18: 323-331, 2009.
41. Sipione S, Simmen KC, Lord SJ, Motyka B, Ewen C, Shostak I, Rayat GR, Dufour JM, Korbutt GS, Rajotte RV, Bleackley RC. Identification of a novel human granzyme B inhibitor secreted by cultured Sertoli cells. J Immunol 177: 5051-5058, 2006.
42. Tang Q, Huang J, Qian H, Xiong R, Shen D, Wu H, Bian Z, Wei X. Microarray analysis reveals the role of matrix metalloproteinases in mouse experimental autoimmune myocarditis induced by cardiac myosin peptides. Cell Mol Biol Lett 12: 176-191, 2007.
43. Taylor LA, Carthy CM, Yang D, Saad K, Wong D, Schreiner G, Stanton LW, sMcManus BM. Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays. Circ Res 87: 328-334, 2000.
44. Wang Y, Jiang H, Dai Su M D, Martinka M, Brasher P, Zhang Y, McLean D, Zhang J, Ip W, Li G, Zhang X, Zhou Y. Alpha 1 antichymotrypsin is aberrantly expressed during melanoma progression and predicts poor survival for patients with metastatic melanoma. Pigment Cell Melanoma Res 23: 575-578, 2010.
45. Wexler RK, Elton T, Pleister A, Feldman D. Cardiomyopathy: an overview. Am Fam Physician 79: 778-784, 2009.
46. Yung CK, Halperin VL, Tomaselli GF, Winslow RL. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics 83: 281-297, 2004.